Gregory Harriman

Dr. Gregory Harriman is an accomplished physician, scientist and biomedical executive having over 25 years of experience in academic medicine and the biopharmaceutical industry. He has held leadership positions in both small and large biopharmaceutical companies, having global responsibilities in research and development of pharmaceuticals, biologics, medical devices and cell therapies. He has led successful regulatory submissions in the U.S., EU and Japan and has presented to FDA Advisory Committees and the EMEA. In previous positions at IVAX, Centocor and J&J, he led clinical R&D groups responsible for the development of both drugs and biologics, including Remicade® (infliximab).